Pathomorphology is correlated with visual acuity changes

Article

The visual acuity (VA) in diabetic retinopathy is associated with the retinal oedema in the parafovea and the pathomorphology and photoreceptor status at the fovea

The visual acuity (VA) in diabetic retinopathy is associated with the retinal oedema in the parafovea and the pathomorphology and photoreceptor status at the fovea claims a study in the American Journal of Ophthalmology.

Dr Tomoaki Murakami and his team at the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan, used 125 consecutive eyes of 73 patients in a retrospective, observational study.

All patients underwent spectralis optical coherence tomography (OCT) and the outcome measures were status of external limiting membrane (ELM), cystic changes and pathomorphology. The correlation of logarithm of the minimal angle of resolution (logMAR) was studied.

Three types of pathomorphology were identified at the fovea. These included cystoid macular oedema (CME), serous retinal detachment (SRD) and a lack of CME or SRD. The average logMAR with the CME pathomorphology was worse than the SRD pathomorphology.

It was found that parafoveal thickening or disturbed ELM was strongly correlated with low VA. However, SRD did not have a strong correlation with VA.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.